Layered Lipid Nanoparticle Adjuvants Coordinate Toll-Like Receptor 4 and Toll-Like Receptor 9 Activation with Enhanced Immunity and Improved Tolerability
- 21 August 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (34) , 24004-24019
Abstract
Vaccines rely on adjuvants to stimulate the immune system, but achieving strong immune activation together with acceptable tolerability remains a major challenge. Lipid nanoparticles are widely used as delivery platforms, yet how their internal organization can be engineered to coordinate multiple innate immune signals remains poorly understood. Here, we designed a hybrid lipid nanoparticle adjuvant that coformulates two clinically relevant immune stimulators targeting toll-like receptor 4 (TLR4) and TLR9. By blending two ionizable lipids, the nanoparticles self-assemble into a layered structure with a raft-associated ordered outer shell and an inner core, with apparent enrichment of monophosphoryl lipid A (MPLA) toward the particle surface and CpG toward the interior, as suggested by our experimental and simulation analyses. This organization is consistent with a relay-like activation pattern that may contribute to strong immune responses while potentially reducing early inflammatory reactions. The hybrid adjuvant enhances antibody quality, cellular immunity, and protective efficacy under the tested conditions, across multiple vaccine antigens and animal models, with performance comparable to or exceeding benchmark adjuvants. These findings suggest that controlling nanoscale lipid organization provides a useful strategy for improving vaccine adjuvant performance.Keywords
Funding Information
- Graduate Program in Physics at UNIFAL-MG (2025YFC2311604)
- Graduate Program in Physics at UNIFAL-MG (2025ZD01904000)
- Graduate Program in Physics at UNIFAL-MG (22405074)
- Graduate Program in Physics at UNIFAL-MG (252301420002)
- Graduate Program in Physics at UNIFAL-MG (82341037)
This publication has 51 references indexed in Scilit:
- The interaction of innate immune and adaptive immune systemMedcomm, 2024
- PEI‐Engineered Lipid@PLGA Hybrid Nanoparticles for Multimodal Delivery of Antigens and Immune Adjuvants to the Respiratory MucosaAdvanced Healthcare Materials, 2024
- Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infectionsActa Biomaterialia, 2022
- Systematic co-delivery of dual agonists to enhance cancer immunotherapyNano Research, 2022
- Mechanism of Membrane Fusion: Interplay of Lipid and PeptideThe Journal of Membrane Biology, 2022
- STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activationNano Research, 2022
- Fabrication of subunit nanovaccines by physical interactionScience China Technological Sciences, 2022
- Below the surface: The inner lives of TLR4 and TLR9Journal of Leukocyte Biology, 2019
- Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signalingCellular and Molecular Life Sciences, 2014
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996